MedTrace Logo

Effect of Cardio Mato (Grade A Lyc-O-Mato, a Tomato Extracted Lycopene) on Blood Pressure

NCT01667510 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2017-12-22

No results posted yet for this study

Summary

The hypothesis of the study is that supplementation with Cardio Mato (a Tomato Extracted Lycopene)for 12 weeks will decrease the blood pressure of subjects with prehypertension compared to Placebo.

Conditions

  • Prehypertension

Interventions

DIETARY_SUPPLEMENT

Cardio Mato

Soft gel capsule for oral use

DIETARY_SUPPLEMENT

Placebo

Soft gel capsule without test material

Sponsors & Collaborators

  • Maccabi Healthcare Services, Israel

    collaborator OTHER

  • LycoRed Ltd.

    lead INDUSTRY

Principal Investigators

  • Arnon Aharon, MD. · LycoRed Ltd.

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-08-31
Primary Completion
2013-06-30
Completion
2013-08-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01667510 on ClinicalTrials.gov